Skip to main content
NCBI home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1984 May;115(2):233–244.

The in vivo effect of leukotriene B4 on polymorphonuclear leukocytes and the microcirculation. Comparison with activated complement (C5a des Arg) and enhancement by prostaglandin E2.

H Z Movat, C Rettl, C E Burrowes, M G Johnston
PMCID: PMC1900498  PMID: 6326579

Abstract

The effect of synthetic leukotriene B4 (LTB4) on chemotaxis in vivo (51Cr-polymorphonuclear leukocyte [PMN] accumulation) was examined and its potency compared with that of C5a des Arg-containing zymosan-activated plasma (ZAP). On a molar basis the amount of C5a des Arg calculated to be in our preparation of ZAP was found to be up to approximately 80 times more potent than LTB4, although in vitro the two chemotaxins have been reported to be about equipotent. ZAP is more representative of what may happen in vivo than its principal constituent C5a des Arg, but for a more precise comparison the purified and isolated peptide will have to be compared with synthetic LTB4. Whereas ZAP induced severe PMN-dependent microvascular injury (increase in vessel permeability [125I-albumin] and hemorrhage [59Fe-erythrocytes]), LTB4 only induced an increase in vascular permeability, and this occurred only in the presence of simultaneously injected prostaglandin E2 (PGE2). PGE2 also enhanced substantially the number of PMNs and the amount of exuded plasma at injection sites of the chemotaxins. However, unlike in two other reports, LTB4 did not cause an immediate transient increase in vessel permeability, nor did it enhance the permeability-increasing effect of bradykinin. Furthermore, unlike PGE2 LTB4 did not induce an increase in blood flow, but a decrease (57Co-microspheres). It is concluded that LTB4 may act as a host-derived chemoattractant in vivo, but, compared with that of ZAP (primarily activated complement), its role in acute inflammation is probably less significant than that of the complement-derived chemotaxin(s).

Full text

PDF
233

Images in this article

239Figure 8
on p.239
240Figure 9
on p.240
241Figure 10
on p.241
242Figure 11
on p.242

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Björk J., Hedqvist P., Arfors K. E. Increase in vascular permeability induced by leukotriene B4 and the role of polymorphonuclear leukocytes. Inflammation. 1982 Jun;6(2):189–200. doi: 10.1007/BF00916243. [DOI] [PubMed] [Google Scholar]
  2. Bray M. A., Cunningham F. M., Ford-Hutchinson A. W., Smith M. J. Leukotriene B4: a mediator of vascular permeability. Br J Pharmacol. 1981 Mar;72(3):483–486. doi: 10.1111/j.1476-5381.1981.tb11000.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bray M. A., Ford-Hutchinson A. W., Smith M. J. Leukotriene B4: an inflammatory mediator in vivo. Prostaglandins. 1981 Aug;22(2):213–222. doi: 10.1016/0090-6980(81)90036-8. [DOI] [PubMed] [Google Scholar]
  4. Crawford J. P., Movat H. Z., Ranadive N. S., Hay J. B. Pathways to inflammation induced by immune complexes: development of the Arthus reaction. Fed Proc. 1982 Jul;41(9):2583–2587. [PubMed] [Google Scholar]
  5. Cybulsky M. I., Movat H. Z. Experimental bacterial pneumonia in rabbits: polymorphonuclear leukocyte margination and sequestration in rabbit lungs and quantitation and kinetics of 51Cr-labeled polymorphonuclear leukocytes in E. coli-induced lung lesions. Exp Lung Res. 1982 Dec;4(1):47–66. doi: 10.3109/01902148209039249. [DOI] [PubMed] [Google Scholar]
  6. Dahlén S. E., Björk J., Hedqvist P., Arfors K. E., Hammarström S., Lindgren J. A., Samuelsson B. Leukotrienes promote plasma leakage and leukocyte adhesion in postcapillary venules: in vivo effects with relevance to the acute inflammatory response. Proc Natl Acad Sci U S A. 1981 Jun;78(6):3887–3891. doi: 10.1073/pnas.78.6.3887. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Feinmark S. J., Lindgren J. A., Claesson H. E., Malmsten C., Samuelsson B. Stimulation of human leukocyte degranulation by leukotriene B4 and its omega-oxidized metabolites. FEBS Lett. 1981 Dec 21;136(1):141–144. doi: 10.1016/0014-5793(81)81233-1. [DOI] [PubMed] [Google Scholar]
  8. Ford-Hutchinson A. W., Bray M. A., Doig M. V., Shipley M. E., Smith M. J. Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes. Nature. 1980 Jul 17;286(5770):264–265. doi: 10.1038/286264a0. [DOI] [PubMed] [Google Scholar]
  9. Ford-Hutchinson A. W., Rackham A., Zamboni R., Rokach J., Roy S. Comparative biological activities of synthetic leukotriene B4 and its omega-oxidation products. Prostaglandins. 1983 Jan;25(1):29–37. doi: 10.1016/0090-6980(83)90132-6. [DOI] [PubMed] [Google Scholar]
  10. Goetzl E. J., Pickett W. C. Novel structural determinants of the human neutrophil chemotactic activity of leukotriene B. J Exp Med. 1981 Feb 1;153(2):482–487. doi: 10.1084/jem.153.2.482. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Goetzl E. J., Pickett W. C. The human PMN leukocyte chemotactic activity of complex hydroxy-eicosatetraenoic acids (HETEs). J Immunol. 1980 Oct;125(4):1789–1791. [PubMed] [Google Scholar]
  12. Goldman D. W., Goetzl E. J. Specific binding of leukotriene B4 to receptors on human polymorphonuclear leukocytes. J Immunol. 1982 Oct;129(4):1600–1604. [PubMed] [Google Scholar]
  13. Hafstrom I., Palmblad J., Malmsten C. L., Rådmark O., Samuelsson B. Leukotriene B4--a stereospecific stimulator for release of lysosomal enzymes from neutrophils. FEBS Lett. 1981 Jul 20;130(1):146–148. doi: 10.1016/0014-5793(81)80684-9. [DOI] [PubMed] [Google Scholar]
  14. Hay J. B., Johnston M. G., Hobbs B. B., Movat H. Z. The use of radioactive microspheres to quantitate hyperemia in dermal inflammatory sites. Proc Soc Exp Biol Med. 1975 Dec;150(3):641–644. doi: 10.3181/00379727-150-39096. [DOI] [PubMed] [Google Scholar]
  15. Higgs G. A., Salmon J. A., Spayne J. A. The inflammatory effects of hydroperoxy and hydroxy acid products of arachidonate lipoxygenase in rabbit skin. Br J Pharmacol. 1981 Oct;74(2):429–433. doi: 10.1111/j.1476-5381.1981.tb09988.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Issekutz A. C. Effect of vasoactive agents on polymorphonuclear leukocyte emigration in vivo. Lab Invest. 1981 Sep;45(3):234–240. [PubMed] [Google Scholar]
  17. Issekutz A. C., Movat H. Z. The effect of vasodilator prostaglandins on polymorphonuclear leukocyte infiltration and vascular injury. Am J Pathol. 1982 Jun;107(3):300–309. [PMC free article] [PubMed] [Google Scholar]
  18. Issekutz A. C., Movat H. Z. The in vivo quantitation and kinetics of rabbit neutrophil leukocyte accumulation in the skin in response to chemotactic agents and Escherichia coli. Lab Invest. 1980 Mar;42(3):310–317. [PubMed] [Google Scholar]
  19. Issekutz A. C., Movat K. W., Movat H. Z. Enhanced vascular permeability and haemorrhage-inducing activity of rabbit C5ades arg: probable role of polymorphonuclear leucocyte lysosomes. Clin Exp Immunol. 1980 Sep;41(3):512–520. [PMC free article] [PubMed] [Google Scholar]
  20. Issekutz A. C., Movat K. W., Movat H. Z. Enhanced vascular permeability and haemorrhage-inducing activity of zymosan-activated plasma. Clin Exp Immunol. 1980 Sep;41(3):505–511. [PMC free article] [PubMed] [Google Scholar]
  21. Johnston M. G., Hay J. B., Movat H. Z. The modulation of enhanced vascular permeability by prostaglandins through alterations in blood flow (hyperemia). Agents Actions. 1976 Nov;6(6):705–711. doi: 10.1007/BF02026092. [DOI] [PubMed] [Google Scholar]
  22. Kopaniak M. M., Hay J. B., Movat H. Z. The effect of hyperemia on vascular permeability. Microvasc Res. 1978 Jan;15(1):77–82. doi: 10.1016/0026-2862(78)90007-9. [DOI] [PubMed] [Google Scholar]
  23. Kopaniak M. M., Issekutz A. C., Burrowes C. E., Movat H. Z. The quantitation of hemorrhage in the skin. Measurement of hemorrhage in the microcirculation in inflammatory lesions and related phenomena. Proc Soc Exp Biol Med. 1980 Jan;163(1):126–131. doi: 10.3181/00379727-163-40733. [DOI] [PubMed] [Google Scholar]
  24. Kopaniak M. M., Movat H. Z. Kinetics of acute inflammation induced by Escherichia coli in rabbits. II. The effect of hyperimmunization, complement depletion, and depletion of leukocytes. Am J Pathol. 1983 Jan;110(1):13–29. [PMC free article] [PubMed] [Google Scholar]
  25. Malmsten C. L., Palmblad J., Udén A. M., Rådmark O., Engstedt L., Samuelsson B. Leukotriene B4: a highly potent and stereospecific factor stimulating migration of polymorphonuclear leukocytes. Acta Physiol Scand. 1980 Dec;110(4):449–451. doi: 10.1111/j.1748-1716.1980.tb06696.x. [DOI] [PubMed] [Google Scholar]
  26. Mencia-Huerta J. M., Razin E., Ringel E. W., Corey E. J., Hoover D., Austen K. F., Lewis R. A. Immunologic and ionophore-induced generation of leukotriene B4 from mouse bone marrow-derived mast cells. J Immunol. 1983 Apr;130(4):1885–1890. [PubMed] [Google Scholar]
  27. O'Flaherty J. T., Wykle R. L., Lees C. J., Shewmake T., McCall C. E., Thomas M. J. Neutrophil-degranulating action of 5,12-dihydroxy-6,8,10,14-eicosatetraenoic acid and 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine. Comparison with other degranulating agents. Am J Pathol. 1981 Dec;105(3):264–269. [PMC free article] [PubMed] [Google Scholar]
  28. Palmblad J., Malmsten C. L., Udén A. M., Rådmark O., Engstedt L., Samuelsson B. Leukotriene B4 is a potent and stereospecific stimulator of neutrophil chemotaxis and adherence. Blood. 1981 Sep;58(3):658–661. [PubMed] [Google Scholar]
  29. Perez H. D., Goldstein I. M., Webster R. O., Henson P. M. Enhancement of the chemotactic activity of human C5a des Arg by an anionic polypeptide ("cochemotaxin") in normal serum and plasma. J Immunol. 1981 Feb;126(2):800–804. [PubMed] [Google Scholar]
  30. Rae S. A., Smith M. J. The stimulation of lysosomal enzyme secretion from human polymorphonuclear leucocytes by leukotriene B4. J Pharm Pharmacol. 1981 Sep;33(9):616–617. doi: 10.1111/j.2042-7158.1981.tb13884.x. [DOI] [PubMed] [Google Scholar]
  31. Ranadive N. S., Sajnani A. N., Alimurka K., Movat H. Z. Release of basic proteins and lysosomal enzymes from neutrophil leukocytes of the rabbit. Int Arch Allergy Appl Immunol. 1973;45(6):880–898. doi: 10.1159/000231087. [DOI] [PubMed] [Google Scholar]
  32. Samuelsson B. Leukotrienes: mediators of allergic reactions and inflammation. Int Arch Allergy Appl Immunol. 1981;66 (Suppl 1):98–106. doi: 10.1159/000232880. [DOI] [PubMed] [Google Scholar]
  33. Showell H. J., Naccache P. H., Borgeat P., Picard S., Vallerand P., Becker E. L., Sha'afi R. I. Characterization of the secretory activity of leukotriene B4 toward rabbit neutrophils. J Immunol. 1982 Feb;128(2):811–816. [PubMed] [Google Scholar]
  34. Sirois P., Borgeat P. Leukotrienes: a new approach to the biochemistry of hypersensitivity. Surv Immunol Res. 1982;1(3):279–285. doi: 10.1007/BF02918470. [DOI] [PubMed] [Google Scholar]
  35. Smith M. J., Ford-Hutchinson A. W., Bray M. A. Leukotriene B: a potential mediator of inflammation. J Pharm Pharmacol. 1980 Jul;32(7):517–518. doi: 10.1111/j.2042-7158.1980.tb12985.x. [DOI] [PubMed] [Google Scholar]
  36. Smith M. J. Leukotriene B4. Gen Pharmacol. 1981;12(4):211–216. doi: 10.1016/0306-3623(81)90047-1. [DOI] [PubMed] [Google Scholar]
  37. Udaka K., Takeuchi Y., Movat H. Z. Simple method for quantitation of enhanced vascular permeability. Proc Soc Exp Biol Med. 1970 Apr;133(4):1384–1387. doi: 10.3181/00379727-133-34695. [DOI] [PubMed] [Google Scholar]
  38. Webster R. O., Hong S. R., Johnston R. B., Jr, Henson P. M. Biologial effects of the human complement fragments C5a and C5ades Arg on neutrophil function. Immunopharmacology. 1980 Jun;2(3):201–219. doi: 10.1016/0162-3109(80)90050-8. [DOI] [PubMed] [Google Scholar]
  39. Wedmore C. V., Williams T. J. Control of vascular permeability by polymorphonuclear leukocytes in inflammation. Nature. 1981 Feb 19;289(5799):646–650. doi: 10.1038/289646a0. [DOI] [PubMed] [Google Scholar]
  40. Williams T. J., Peck M. J. Role of prostaglandin-mediated vasodilatation in inflammation. Nature. 1977 Dec 8;270(5637):530–532. doi: 10.1038/270530a0. [DOI] [PubMed] [Google Scholar]
  41. Williams T. J., Piper P. J. The action of chemically pure SRS-A on the microcirculation in vivo. Prostaglandins. 1980 May;19(5):779–789. doi: 10.1016/0090-6980(80)90174-4. [DOI] [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES